News >

Lilly Acquires Loxo Oncology in $8 Billion Deal

Gina Columbus @ginacolumbusonc
Published: Monday, Jan 07, 2019

Daniel Skovronsky, MD, PhD

Daniel Skovronsky, MD, PhD

Eli Lilly and Company has announced that it will acquire the biopharmaceutical company Loxo Oncology for 5 per share in cash or an estimated billion. The transaction is expected to close by end of March 2019.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Advances in™ Multiple Myeloma: Changing Treatment Paradigms and the Emerging Potential of CAR T-Cell TherapyAug 30, 20191.5
Publication Bottom Border
Border Publication
x